...
首页> 外文期刊>Acta biomaterialia >Surface mineralization of Ti6Al4V substrates with calcium apatites for the retention and local delivery of recombinant human bone morphogenetic protein-2.
【24h】

Surface mineralization of Ti6Al4V substrates with calcium apatites for the retention and local delivery of recombinant human bone morphogenetic protein-2.

机译:用钙磷灰石对Ti6Al4V基底进行表面矿化,以保留和局部递送重组人骨形态发生蛋白2。

获取原文
获取原文并翻译 | 示例

摘要

Titanium alloys are prevalently used as orthopedic prosthetics. Inadequate bone-implant interactions can lead to premature prosthetic loosening and implant failure. Local delivery of osteogenic therapeutics promoting osteointegration of the implant is an attractive strategy to address this clinical challenge. Given the affinity of calcium apatites for bone matrix proteins we hypothesize that titanium alloys surface mineralized with calcium apatites should be explored for the retention and local delivery of osteogenic recombinant human bone morphogenetic protein-2 (rhBMP-2). Using a heterogeneous surface nucleation and growth process driven by the gradual pH elevation of an acidic solution of hydroxyapatite via thermal decomposition of urea, Ti6Al4V substrates were surface mineralized with calcium apatite domains exhibiting good affinity for the substrate. The microstructures, size and surface coverage of the mineral domains as a function of the in vitro mineralization conditions were examined by light and scanning electron microscopy and the surface calcium ion content quantified. An optimal mineralization condition was identified to rapidly (<10h) achieve surface mineral coverage far superior to those accomplished by week long incubation in simulated body fluids. In vitro retention-release profiles of rhBMP-2 from the mineralized and unmineralized Ti6Al4V, determined by an enzyme-linked immunosorbent assay, supported a higher degree of retention of rhBMP-2 on the mineralized substrate. The rhBMP-2 retained on the mineralized substrate after 24h incubation in phosphate-buffered saline remained bioactive, as indicated by its ability to induce osteogenic transdifferentiation of C2C12 myoblasts attached to the substrate. This mineralization technique could also be applied to the surface mineralization of calcium apatites on dense tantalum and titanium and porous titanium substrates.
机译:钛合金普遍用作矫形假体。骨与植入物之间的相互作用不足会导致假体过早松弛和植入物失效。促进植入物骨整合的成骨治疗剂的局部递送是解决该临床挑战的有吸引力的策略。考虑到钙磷灰石对骨基质蛋白的亲和力,我们假设应该探索用钙磷灰石矿化的钛合金表面的成骨重组人骨形态发生蛋白2(rhBMP-2)的保留和局部递送。使用异质性表面成核和生长过程,该过程由羟基磷灰石的酸性溶液通过尿素的热分解逐渐提高pH值驱动,Ti6Al4V衬底被矿化了钙磷灰石结构域,从而显示出对衬底的良好亲和力。通过光学和扫描电子显微镜检查矿物域的微结构,大小和表面覆盖率与体外矿化条件的关系,并对表面钙离子含量进行定量。确定了最佳矿化条件,可以快速(<10h)达到表面矿物质覆盖率,远胜于在模拟体液中孵育一周后实现的覆盖率。通过酶联免疫吸附测定确定的从矿化和未矿化的Ti6Al4V的rhBMP-2的体外保留释放曲线,支持了rhBMP-2在矿化基质上的更高保留度。 rhBMP-2在磷酸盐缓冲液中孵育24小时后保留在矿化底物上,如其诱导附着在底物上的C2C12成肌细胞的成骨转分化能力所表明的那样,它仍然具有生物活性。该矿化技术还可应用于致密钽和钛以及多孔钛基底上的磷灰石钙的表面矿化。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号